GRI Bio Participates in Virtual Investor KOL Connect Segment
GRI Bio, Inc. (GRI)
Company Research
Source: GlobeNewswire
Albert Agro, PhD, CMO of GRI Bio recently participated in a Virtual Investor KOL Connect segment with prominent key opinion leader in Idiopathic Pulmonary Fibrosis (IPF) – Dr. Helen Parfrey, Respiratory Consultant at the Royal Papworth Hospital and Affiliated Assistant Professor at the University of Cambridge Company advancing GRI-0621 toward interim data readout of Phase 2a biomarker study in Q4 2024 and topline data in Q1 2025 Access the segment here LA JOLLA, CA, Sept. 18, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio,” “we,” “our,” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced its participation in a recent Virtual Investor KOL Connect segment. As part of the segment, Albert Agro, PhD, Chief Medical Officer of GRI Bio and Dr. Helen Parfrey, Respiratory Consultant at Royal Papworth Hospital and Aff
Show less
Read more
Impact Snapshot
Event Time:
GRI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRI alerts
High impacting GRI Bio, Inc. news events
Weekly update
A roundup of the hottest topics
GRI
News
- GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in AustraliaGlobeNewswire
- GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect SegmentGlobeNewswire
- GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment Conference [Yahoo! Finance]Yahoo! Finance
- GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewswire
- GRI Bio to Present at the 2024 European Respiratory Congress [Yahoo! Finance]Yahoo! Finance
GRI
Sec Filings
- 9/11/24 - Form 8-K/A
- 9/11/24 - Form 424B3
- 9/11/24 - Form 424B3
- GRI's page on the SEC website